¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hormone deficiency"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gonadotropic hormone
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó, »ý½Ä¼±ÀÚ±ØÈ£¸£¸ó
  • gonadotropin-releasing hormone
    »ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó, »ý½Ä¼±ÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó
  • gonadotropin-releasing hormone agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸ó¹æÃâÈ£¸£¸óÀÛ¿ëÁ¦
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • hypophysiotropic hormone
    ³úÇϼöüÀÚ±ØÈ£¸£¸ó
  • hypothalamic inhibitory hormone
    ½Ã»óÇϺξïÁ¦È£¸£¸ó
  • hypothalamic releasing hormone
    ½Ã»óÇϺκкñÈ£¸£¸ó
  • hormone
    È£¸£¸ó
  • hormone bombardment
    È£¸£¸óÃæ°Ý¿ä¹ý
  • hormone dependent
    È£¸£¸óÀÇÁ¸-
  • hormone replacement therapy
    È£¸£¸ó´ëġġ·á
  • hormone therapy
    È£¸£¸ó¿ä¹ý
  • inhibitory hormone
    ¾ïÁ¦È£¸£¸ó
  • interstitial cell-stimulating hormone
    »çÀÌÁú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó, °£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó
  • local hormone
    ±¹¼ÒÈ£¸£¸ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nutritional deficiency syndrome
    ¿µ¾ç°áÇÌÁõÈıº
  • adrenal corticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • adrenomedullary hormone
    ºÎ½Å¼ÓÁúÈ£¸£¸ó
  • androgenic hormone
    ³²¼ºÈ£¸£¸ó
  • antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
  • hormone bombardment
    È£¸£¸óÃæ°Ý¿ä¹ý
  • corticosteroid hormone
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • corticotropin-releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
  • diabetogenic hormone
    ´ç´¢º´¹ß»ýÈ£¸£¸ó
  • digestive hormone
    ¼ÒÈ­È£¸£¸ó
  • hormone dependent
    È£¸£¸óÀÇÁ¸
  • ectopic hormone
    µý°÷È£¸£¸ó
  • embryonic hormone
    ¹è¾ÆÈ£¸£¸ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • apolipoprotein C-Il deficiency
    ¾ÆÆ÷Áö´Ü¹é C-II °áÇÌ
  • apolipoprotein b, deficiency
    ¾ÆÆ÷¸®Æ÷´Ü¹éB°áÇÌÁõ(¡­Ó±ÛÜ¡­ÌÀù¹ñø)
  • arylsulfatase a deficiency
    ¾Æ¸±¼³ÆÄŸÁ¦ A °áÇÌÁõ(¡­ÌÀù¹ñø)
  • aspartylglycosamine amide hydrolase, deficiency
    Aspartylglycosamine amide hydrolase°áÇÌ(¡­ÌÀù¹)
  • functional deficiency
    ±â´É°áÇÌ
  • g6pd deficiency
    G6PD(Æ÷µµ´ç-6-Àλ꿰 Å»¼ö¼ÒÈ¿¼Ò) °áÇÌÁõ
  • galactosidase, alpha-galactosidase a, deficiency
    #NAME?
  • glucocerebrosidase deficiency
    ±Û·çÄÚ¼¼·¹ºê·Î½Ãµ¥À̽º °áÇÌÁõ
  • glucose 6 phosphatase deficiency hepa
    ±Û·çÄÚ¿À½º-6 -ÀÎ»ê °áÇ̰£½ÅÇü´ç
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀÌ µå·ÎÀú³×À̽º °áÇÌ(Áõ)
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glycosidase deficiency
    ±Û¸®ÄڽôپÆÁ¦°áÇÌ(Áõ).
  • gonadal deficiency
    »ý½Ä¼±ºÎÀü(ßæãÖàÍÝÕîï).
  • gonadal deficiency
    »ý½Ä¼±ºÎÀü(ßæãÖàÍÝÕîï).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ectopic hormone secretion
    À̼ҼºÈ£¸£¸óºÐºñ
  • embryonic hormone
    ¹è(ÛÏ)È£¸£¸ó.
  • estrogenic hormone
    ¸®¹ßÁ¤(Û¡ï×)È£¸£¸ó.
  • estrogenic hormone
    ¹ßÁ¤(Û¡ï×)È£¸£¸ó.
  • estrogenic hormone
    ¸®¹ßÁ¤(Û¡ï×)È£¸£¸ó.
  • female hormone
    ¿©¼º(åüàõ)È£¸£¸ó.
  • follicle hormone =follicular h.
    ³­Æ÷È£¸£¸ó.
  • follicle stimulating hormone
    ³­Æ÷ÀÚ±ØÈ£¸£¸ó
  • follicle stimulating hormone
    ³­Æ÷ÀÚ±ØÈ£¸£¸ó(Õ°øàí©Ð½¡­)
  • follicle stimulating hormone =FSH
    ³­Æ÷ÀÚ±ØÈ£¸£¸ó(Õ°øàô§Ð½¡­).
  • follicle-stimulating hormone
    ¿©Æ÷ÀÚ±ØÈ£¸£¸ó
  • gametocinetic hormone
    ³­Æ÷ÀÚ±Ø(Õ°øàô§ н)È£¸£¸ó.
  • gametogenic hormone
    »ý½Ä¹ß»ýÈ£¸£¸ó, ¹è¿ìÀڹ߻ýÈ£¸£¸ó.
  • geniotrophic hormone =GTH
    Çâ»ý½Ä¼±(ú¾ßæãÖàÍ)È£¸£¸ó.
  • gestagenic hormone
    ÇÁ·ÎÁ¦½ºÅ×·Ð.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • corticotropin releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ À¯¸®(ë´×î) È£¸£¸ó
  • diabetogenic hormone
    ´ç´¢º´¹ß»ý(ÓØÒãÜ»Û¡ßæ)È£¸£¸ó
  • eclosion hormone
    ¿ìÈ­(éâûù) È£¸£¸ó
  • ectopic hormone syndrome
    À̼Ò(ì¶á¶) È£¸£¸ó ÁõÈıº(ñøý¦ÏØ)
  • emergency hormone
    ÀÀ±Þ(ëëÐá) È£¸£¸ó
  • female sex hormone
    ¿©¼º(Ò³àõ) ¼º(àõ)È£¸£¸ó
  • flowering hormone
    °³È­(ËÒü£) È£¸£¸ó
  • follicle-stimulating hormone
    ³­Æ÷ÀÚ±Ø(Õ°øàí©Ð½) È£¸£¸ó
  • gonadotrophic hormone
    ¼º¼±ÀÚ±Ø(àõàÍí©Ð½)È£¸£¸ó
  • gonadotropic hormone
    ¼º¼±ÀÚ±Ø(àõàÍí©Ð½)È£¸£¸ó
  • gonadotropin releasing hormone
    °í³ªµµÆ®·ÎÇÉ ¹æÃâ(Û¯õó)È£¸£¸ó
  • growth hormone
    ¼ºÀå(à÷íþ)È£¸£¸ó
  • hormone
    È£¸£¸ó
  • hypothalamic hormone
    ½Ã»óÇϺÎ(ãÊßÉù»Ý») È£¸£¸ó
  • interstitial cell hormone
    °£Áú¼¼Æ÷(Êàòõá¬øà) È£¸£¸ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FSH-RH Follicle Stimulating Hormone Releasing Hormone
GHRH Growth Hormone Releasing Hormone
GIH Growth hormone release Inhibiting Hormone
  = Somatostatin
GRH Growth hormone Releasing Hormone
FRH follicle-stimulating hormone-releasing hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
hGHRH Human growth-hormone-releasing hormone
LH-RH Luteinising Hormone-Releasing Hormone
LRH Luteinizing Hormone Releasing Hormone
LHRH-A luteinizing hormone releasing hormone agonist
LHRHa leuteinizing hormone-releasing hormone analogue
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • melanophorotropic hormone
    ¸á¶ó³ëÆ÷¸£ ģȭ¼º È£¸£¸ó
  • molting hormone
    Å»ÇÇ È£¸£¸ó
  • N-hormone
    N-È£¸£¸ó
    ºÎ½Å ÇÇÁú ³»ºÐºñ È£¸£¸óÀÇ Çϳª.
  • natriuretic hormone
    ³ªÆ®·ý ¹è¼³ Áõ°¡ È£¸£¸ó, ³ªÆ®·ý ¹è¼³ ÃËÁø È£¸£¸ó
  • pancreatic hormone
    ÃéÀå È£¸£¸ó
  • parathyroid hormone
    ºÎ°©»ó¼± È£¸£¸ó
    1. ºÎ°©»ó¼± È£¸£¸óÀÇ ÁÖ¿ä »ý¸®Àû ±â´ÉÀº ´ÙÀ½°ú °°´Ù.
  • parathyroid hormone-related peptide
    ºÎ°©»ó¼± È£¸£¸ó ¿¬°ü ÆéŸÀ̵å
  • peptide hormone
    ÆéƼµå È£¸£¸ó
  • placental hormone
    Źݼº È£¸£¸ó, ÅÂ¹Ý È£¸£¸ó
    Æ÷À¯·ùÀÇ Å¹ݿ¡¼­ ºÐºñµÇ´Â È£¸£¸ó. »ç¶÷, ¿ø¼þÀÌ µî¿¡¼­ º¼ ¼ö ÀÖ´Â »ý½Ä¼± ÀÚ±Ø È£¸£¸óÀÇ ºÐºñ¶ó°í ÁÖÀåÇÏ´Â ÇÐÀÚµµ ÀÖ´Ù. ´Ù¸¸ À̵é È£¸£¸óÀÇ ÀÛ¿ëÀº ³úÇϼöü Àü¿±ÀÇ »ý½Ä¼± ÀÚ±Ø È£¸£¸ó°ú´Â »ý¸® ÀÛ¿ëÀÌ ´Ù¸£´Ù. ¶Ç ¿©·¯ µ¿¹°ÀÇ Å¹ÝÀº ¹ßÁ¤ È£¸£¸ó, Ȳü È£¸£¸óÀ» ºÐºñÇÏ¿© ³­¼ÒÀÇ ³»ºÐºñ Ȱµ¿¿¡ ¿µÇâÀ» ¹ÌÄ¡°í, ³ª¾Æ°¡¼­´Â »ý½Ä°è ÀüüÀÇ Àӽű⿡ ƯÀ¯ÇÑ »óÅÂÀÇ À¯Áö¿¡ °ü¿©Çϰí ÀÖ´Ù. ÄÚ¸£Æ¼ÄÚÀ̵åÀÇ »ý»ê, ºÐºñ °¡´É¼ºµµ Á¡Â÷ ÀÎÁ¤µÇ¾î ÀÌµé ¿©·¯ °¡Áö È£¸£¸ó ºÐºñ Á¶Á÷¿¡ °üÇÑ ¿¬±¸µµ ÁøÇàµÇ°í ÀÖ´Ù.
  • salivary gland hormone
    Ÿ¾×¼± È£¸£¸ó, Ÿ¾×»ù È£¸£¸ó
  • sex hormone
    ¼º È£¸£¸ó
  • thyrotropic hormone
    °©»ó¼± ÀÚ±Ø È£¸£¸ó
    µ¿ÀǾî=thyrotro
  • 17-hydroxylase deficiency
    17-hydroxylase °áÇÌ
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
    1. ÇöÀúÇÑ ¸é¿ª °áÇ̰ú ÇÔ²² ±âȸ°¨¿°, ¼Ó¹ß¼º ¾Ï ¹× ½Å°æ°è Áõ¼¼°¡ µ¿¹Ý. ¹ÙÀÌ·¯½º ÀÚü¿¡ ÀÇÇÑ º´º¯°ú ¸é¿ª´É·Â ÀúÇÏ¿¡ µû¸¥ ±âȸ °¨¿° µîÀÇ ÀÌÂ÷Àû º´º¯ÀÇ µÎ °¡Áö·Î ´ëº°. HIV¿¡ ÀÇÇØ ¹ß»ýµÇ´Â ÁúȯÀ¸·Î ½Å°æ°è°¡ Áß¿ä Ç¥ÀûÁß Çϳª. ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ »ç¶÷ÀÇ 40% Á¤µµ°¡ Áúº´ÀÌ ¹ß»ý. ¹ÙÀÌ·¯½ºÀÇ Á÷Á¢ÀûÀÎ ¿µÇâ¿¡ ÀÌÇÑ º´º¯À¸·Î´Â ¸²ÇÁ±¸¼º ¼ö¸·¿°°ú HIV ³ú¿° µîÀÌ ÀÖÀ½. 2. ÈÄõ¼º ¸é¿ª°áÇÌÁõ. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
vitamin a deficiency A nutritional condition produced by a deficiency of vitamin a in the diet, characterised by night blindness and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (xerophthalmia). Vitamin a deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin a-rich foods. In the united states it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption.
(12 Dec 1998)
vitamin B12 deficiency A form of anaemia (low red blood cell counts) that results when the bone marrow fails to produce adequate numbers of red blood cells due to a deficiency in vitamin B12. Intrinsic factor, necessary for normal B12 absorption, may be the underlying cause for B12 deficiency if is not produced in the gastric glands (in the stomach).
(27 Sep 1997)
vitamin b 12 deficiency A nutritional condition produced by a deficiency of vitamin b 12 in the diet, characterised by megaloblastic anaemia. Since vitamin b 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin b 12 deficiency and appears to be due to an undefined defect involving myelin synthesis.
(12 Dec 1998)
vitamin B6 deficiency Member of the water soluble B vitamin group. Vitamin B6 or pyridoxine, is active in the metabolism of proteins, carbohydrates and fats. It is also a necessary part of haemoglobin synthesis. B6 deficiency results in retarded growth and a peripheral neuropathy.
(27 Sep 1997)
vitamin C deficiency A disease due to the deficiency of vitamin C (ascorbic acid).
Symptoms include weakness, anaemia, spongy gums and mucocutaneous bleeding (mouth ulcers).
Synonym: scurvy.
(27 Sep 1997)
vitamin D deficiency A vitamin D deficiency disease of infancy or childhood with a disturbance of the normal process of ossification and bone growth. Often manifests with bone deformity.
(27 Sep 1997)
vitamin e deficiency A nutritional condition produced by a deficiency of vitamin e in the diet, characterised by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin e deficiency is associated with haemolytic anaemia, thrombocytosis, oedema, intraventricular haemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin e metabolism, named familial isolated vitamin e deficiency, has recently been identified. (cecil textbook of medicine, 19th ed, p1181)
(12 Dec 1998)
glucose-6-dehydrogenase deficiency <biochemistry> An inherited condition that results in a deficiency in glucose-6-phosphate dehydrogenase. Particular drugs (sulphonamides) can exacerbate this problem. The result is haemolytic anaemia.
(27 Sep 1997)
cellular immunity deficiency syndrome <syndrome> A syndrome marked by increased susceptibility to infection, especially to viral infection, associated with defective functioning of the mechanism responsible for acquired immunity of the cell-mediated kind.
See: immunodeficiency.
(05 Mar 2000)
glucose-6-phosphate dehydrogenase deficiency A deficiency of glucose-6-phosphate dehydrogenase, an enzyme important for maintaining cellular concentrations of reduced nucleotides.
Deficiency of this enzyme is the commonest disease-causing enzyme defect in humans affecting an estimated 400 million people.
The gene for this enzyme is on the X chromosome and there are various polymorphic forms.
Males with the enzyme deficiency develop haemolytic anaemia when red blood cells are exposed to oxidant drugs such as the antimalarial primaquine, the sulfonamide antibiotics or sulfones, naphthalene moth balls, or fava beans. It can also cause anaemia of the newborn, and chronic nonspherocytic haemolytic anaemia.
Inheritance: X-linked.
(12 Sep 2002)
vitamin k deficiency A nutritional condition produced by a deficiency of vitamin k in the diet, characterised by an increased tendency to haemorrhage (haemorrhagic diathesis). Such bleeding episodes may be particularly severe in newborn infants.
(12 Dec 1998)
glucosephosphate dehydrogenase deficiency A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to haemolytic anaemia.
(12 Dec 1998)
glucosephosphate isomerase deficiency <enzyme> An enzyme deficiency characterised by chronic nonspherocytic haemolytic anaemia; autosomal recessive inheritance.
Synonym: phosphohexose isomerase deficiency.
(05 Mar 2000)
glutathione synthetase deficiency An inborn error of metabolism associated with massive urinary excretion of 5-oxyproline, elevated levels of 5-oxyproline in the blood and cerebrospinal fluid, severe metabolic acidosis, tendency toward haemolysis, and defective central nervous systems function. Glutathione synthetase deficiency has been reported as a generalised condition or with a deficiency restricted to erythrocytes.
(05 Mar 2000)
mental deficiency Subnormal intellectual functioning which originates during the developmental period and is associated with impairment of one or more of the following: (1) maturation, (2) learning, (3) social adjustment.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á